日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Evaluating the association of antibiotic spectrum and treatment responses of cystic fibrosis pulmonary exacerbations

评估抗生素谱与囊性纤维化肺部急性加重治疗反应之间的关联

Somayaji, Ranjani; Cogen, Jonathan D; VanDevanter, Donald; LiPuma, John J; West, Natalie E; Sanders, Don B; Gerber, Jeffrey S; Kronman, Matthew P; Goss, Christopher H; Flume, Patrick A; Heltshe, Sonya L

Correlates of FEV₁ deficit in pulmonary exacerbations of cystic fibrosis and associated clinical outcomes

囊性纤维化肺部急性加重期FEV₁不足的相关因素及相关临床结局

McElvaney, Oliver J; Heltshe, Sonya L; Sanders, Don B; West, Natalie E; Fogarty, Barbra; VanDevanter, Donald R; Flume, Patrick A; Goss, Christopher H

Evaluating Long-Term Effectiveness of Cystic Fibrosis Modulator Therapies after Rapid Adoption: A Dual-Approach Study

快速推广应用后评估囊性纤维化调节剂疗法的长期疗效:一项双重方法研究

Miranda Afonso, Pedro; Zhou, Grace C; Su, Weiji; Burgel, Pierre-Régis; Cromwell, Elizabeth; Goss, Christopher H; Keogh, Ruth H; Liou, Theodore G; Marshall, Bruce C; Mayer-Hamblett, Nicole; Morgan, Wayne J; Ostrenga, Joshua S; Pasta, David J; Schechter, Michael S; Stanojevic, Sanja; Wainwright, Claire E; Szczesniak, Rhonda D; Andrinopoulou, Eleni-Rosalina

Risk Factors for Longitudinal eGFR Decline in Adults with Cystic Fibrosis

囊性纤维化成人患者纵向eGFR下降的风险因素

Nacharaju, Deepthi; Zelnick, Leila R; Ramos, Kathleen J; de Boer, Ian H; Flume, Patrick A; Goss, Christopher H; Heltshe, Sonya L; Bhatraju, Pavan K

Maximising opportunity for therapeutic success: sequential participation in cystic fibrosis nucleic acid-based therapy trials

最大限度提高治疗成功率:按顺序参与囊性纤维化核酸疗法试验

Mayer-Hamblett, Nicole; Kerper, Natanya R; Clancy, John P; Davies, Jane C; Taylor-Cousar, Jennifer L; Donaldson, Scott H; Bell, Scott C; Jain, Raksha; Simmonds, Nicholas J; Mall, Marcus A; Goss, Christopher H; Rayment, Jonathan H; Setiawan, Linda; Pilewski, Joseph M

Cystic Fibrosis Microbiome-directed Antibiotic Therapy Trial in Exacerbations Results Stratified (CFMATTERS): results of a multicentre randomised controlled trial

囊性纤维化急性加重期微生物组导向抗生素治疗试验结果分层分析(CFMATTERS):一项多中心随机对照试验的结果

Plant, Barry J; Einarsson, Gisli G; Deasy, Kevin F; Dahly, Darren; Singh, Pradeep K; Barry, Peter J; Goss, Christopher H; Fajac, Isabelle; Vagg, Tamara; Durieu, Isabelle; Flanagan, Evelyn; O'Callaghan, Grace; Martin, Clémence; Burgel, Pierre-Régis; Haworth, Charles S; Floto, R Andres; Downey, Damian G; Dupont, Lieven J; Jones, Andrew M; Elborn, J Stuart; Eustace, Joseph A; Mall, Marcus A; Tunney, Michael M

Pseudomonas infections persisting after CFTR modulators are widespread throughout the lungs and drive lung inflammation

即使使用CFTR调节剂,铜绿假单胞菌感染仍会持续存在于肺部各处,并引发肺部炎症。

Durfey, Samantha L; Kapnadak, Siddhartha G; Pena, Tahuanty; Willmering, Matthew M; Godwin, J David; Teresi, Mary E; Heltshe, Sonya L; Vo, Anh T; Villacreses, Raul A; Aliukonyte, Ieva; Boyken, Linda; Stroik, Mal R; Morgan, Sarah J; Wang, Grace M; Betts, Hannah L; Zhang, Shide; Goss, Christopher H; Clancy, John P; Aitken, Moira L; Steele, Chad; Feder, Alison F; Esther, Charles R Jr; Tiddens, Harm A W M; Woods, Jason C; Stoltz, David A; Singh, Pradeep K

Elexacaftor/tezacaftor/ivacaftor prescription in lung transplant recipients with cystic fibrosis in the US

美国肺移植受者中囊性纤维化患者使用Elexacaftor/tezacaftor/ivacaftor处方

Burdis, Nora C; Bradford, Miranda C; Heltshe, Sonya L; Milinic, Tijana; McElvaney, Oliver J; Lease, Erika D; Goss, Christopher H; Kapnadak, Siddhartha G; Guthrie, Brandon L; Ramos, Kathleen J

Aging with CF: Characteristics of people with CF aged 40 and older in the United States

囊性纤维化患者的老龄化:美国40岁及以上囊性纤维化患者的特征

Ostrenga, Joshua S; Robinson, Kristina; Brown, A Whitney; Goss, Christopher H; Cromwell, Elizabeth A

An alternative view of changes in lung function among people with cystic fibrosis

囊性纤维化患者肺功能变化的另一种观点

McElvaney, Oliver J; Goss, Christopher H